Imiquimod, a Toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro-Reference-Cited by-同舟云学术

Imiquimod, a Toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro

Published:2004-04 Issue:18 Volume:40 Page:1307-1314
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Ambach Andreas,Bonnekoh Bernd,Nguyen Myhan,Schön Michael P.,Gollnick Harald

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference39 articles.

1. Perforin hyperreleasability and depletion in cytotoxic T cells from patients with exacerbated atopic dermatitis and asymptomatic rhinoconjunctivitis allergica;Ambach;J. Allergy Clin. Immunol.,2001

2. Perforin granule release from cytotoxic lymphocytes ex vivo is inhibited by ciclosporin, but not by methotrexate;Ambach;Skin Pharmacol. Appl. Physiol.,2001

3. UVA1-induced suppression of perforin-granule release from CD8+ cytotoxic T lymphocytes ex vivo;Ambach;Arch. Dermatol. Res.,2001

4. Routine flow cytometric immuno-staining of T-cellular perforin is preserved using diethylene glycol for erythrocyte-lysis but lost by the use of ammonium chloride;Ambach;Exp. Dermatol.,2003

5. Increasing the cytotoxic capacity of peripheral CD8+ T lymphocytes by adjuvant high dose-therapy with Interferon-alpha 2b in patients with malignant melanoma;Ambach;JDDG,2003

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glutamine promotes human CD8+ T cells and counteracts imiquimod-induced T cell hyporesponsiveness;iScience;2024-05

2. Imiquimod tópico para tratar la micosis fungoide en fase tumoral con pocos nódulos o nódulos aislados;Piel;2023-11

3. Preclinical study models of psoriasis: State-of-the-art techniques for testing pharmaceutical products in animal and nonanimal models;International Immunopharmacology;2023-04

4. Topical and Intralesional Antiviral Agents;Comprehensive Dermatologic Drug Therapy;2021

5. Topical Therapy for the Treatment of Basal Cell Carcinoma;Basal Cell Carcinoma;2019-12-18